{"id":"https://openalex.org/W188923403","doi":null,"title":"Raltegravir use prospectively assessed in a major HIV outpatient clinic in Italy: sample population, virological-immunological activity, and tolerability profile.","display_name":"Raltegravir use prospectively assessed in a major HIV outpatient clinic in Italy: sample population, virological-immunological activity, and tolerability profile.","publication_year":2014,"publication_date":"2014-12-01","ids":{"openalex":"https://openalex.org/W188923403","mag":"188923403","pmid":"https://pubmed.ncbi.nlm.nih.gov/25551844"},"language":"en","primary_location":{"id":"pmid:25551844","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25551844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Le infezioni in medicina","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051980640","display_name":"Roberto Manfredi","orcid":"https://orcid.org/0000-0001-9022-9893","observed_orcids":["https://orcid.org/0000-0001-9022-9893"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Manfredi","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046270633","display_name":"Leonardo Calza","orcid":"https://orcid.org/0000-0002-1895-1504","observed_orcids":["https://orcid.org/0000-0002-1895-1504"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Leonardo Calza","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109322001","display_name":"Ginevra Marinacci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ginevra Marinacci","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025367866","display_name":"Alessandra Cascavilla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandra Cascavilla","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048376546","display_name":"Vincenzo Colangeli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vincenzo Colangeli","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084078904","display_name":"Caterina Salvadori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Caterina Salvadori","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101985573","display_name":"Giulia Martelli","orcid":"https://orcid.org/0000-0003-4169-3379","observed_orcids":["https://orcid.org/0000-0003-4169-3379"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Martelli","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018711457","display_name":"Lucia Appolloni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lucia Appolloni","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068495707","display_name":"Cristina Puggioli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cristina Puggioli","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045135007","display_name":"Pierluigi Viale","orcid":"https://orcid.org/0000-0003-1264-0008","observed_orcids":["https://orcid.org/0000-0003-1264-0008"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pierluigi Viale","raw_affiliation_strings":["Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy; Hospital Pharmacy, S. Orsola-Malpighi Hospital, Bologna, Italy","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.467,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.66194988,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"22","issue":"4","first_page":"288","last_page":"95"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hiv-integrase-inhibitors","display_name":"HIV integrase inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.621999979019165},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6639999747276306},{"id":"https://openalex.org/keywords/virological-response","display_name":"virological response","score":0.6389999985694885},{"id":"https://openalex.org/keywords/immune-response","display_name":"immune response","score":0.8999999761581421},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6480000019073486},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7319999933242798},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.5320000052452087},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9539999961853027},{"id":"https://openalex.org/keywords/liver-cirrhosis","display_name":"liver cirrhosis","score":0.8980000019073486},{"id":"https://openalex.org/keywords/hiv-associated-malignancies","display_name":"HIV-associated malignancies","score":0.5559999942779541},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5410000085830688},{"id":"https://openalex.org/keywords/darunavir-ritonavir","display_name":"darunavir/ritonavir","score":0.7739999890327454},{"id":"https://openalex.org/keywords/maraviroc","display_name":"maraviroc","score":0.9929999709129333},{"id":"https://openalex.org/keywords/etravirine","display_name":"etravirine","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.9935969114303589},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7977713346481323},{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.7843267917633057},{"id":"https://openalex.org/C2780345285","wikidata":"https://www.wikidata.org/wiki/Q414762","display_name":"Etravirine","level":5,"score":0.7723226547241211},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6952689290046692},{"id":"https://openalex.org/C2778899366","wikidata":"https://www.wikidata.org/wiki/Q421369","display_name":"Maraviroc","level":3,"score":0.6096274256706238},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.5777066349983215},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5517532229423523},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.529689610004425},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5162441730499268},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.47483545541763306},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.4700174629688263},{"id":"https://openalex.org/C2777275308","wikidata":"https://www.wikidata.org/wiki/Q234668","display_name":"Cart","level":2,"score":0.4318041205406189},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.38704442977905273},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2973565459251404},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2861108183860779},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2552756667137146},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.22415977716445923},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.13388019800186157},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068898","descriptor_name":"Raltegravir Potassium","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000554","descriptor_name":"Ambulatory Care Facilities","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:25551844","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25551844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Le infezioni in medicina","raw_type":"Journal Article"},{"id":"mag:188923403","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25551844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7005448533","https://openalex.org/W7096021204","https://openalex.org/W2000934747","https://openalex.org/W2148544227","https://openalex.org/W2109360985","https://openalex.org/W2021383468","https://openalex.org/W1976475396","https://openalex.org/W2006715152","https://openalex.org/W2944928590","https://openalex.org/W2118362719"],"abstract_inverted_index":{"Raltegravir,":[0],"as":[1,281],"the":[2,38,40,44,111,219,230,238,263,347,437],"first":[3],"HIV":[4,17,85,213],"integrase":[5],"inhibitor,":[6],"has":[7],"been":[8],"used":[9],"and":[10,43,159,182,191,199,216,291,302,338,358,406,416,431],"prospectively":[11],"monitored":[12,97],"since":[13],"2010":[14],"in":[15,128,197,283,299,312,366,378,428],"our":[16,29],"outpatient":[18],"centre,":[19],"where":[20],"over":[21],"1,200":[22],"patients":[23,49,68,135,227,259,284,314,368,430],"are":[24],"monitored.":[25],"The":[26,146,163,203],"aim":[27],"of":[28,37,47,84,114,117,132,195,205,212,218,222,245,315,414,440],"report":[30],"is":[31],"to":[32,143,234,254,294,352,355,442],"perform":[33],"an":[34],"interim":[35],"assessment":[36],"background,":[39],"safety":[41,407],"profile":[42],"clinical-laboratory":[45,210,249],"monitoring":[46],"all":[48,209,370],"treated":[50],"with":[51,81,307,317,346,400,420],"a":[52,70,82,139,243,411],"combination":[53],"antiretroviral":[54,150],"therapy":[55],"(cART)":[56],"including":[57],"raltegravir,":[58,255],"for":[59,98,225],"at":[60,99],"least":[61,100],"12":[62,101],"months.":[63],"In":[64,110],"all,":[65],"109":[66,133],"pretreated":[67],"started":[69],"raltegravir-containing":[71,231,321],"cART":[72,123,232,433],"when":[73],"aged":[74],"44.8":[75],"plus":[76,89,105],"or":[77,90,106,177],"minus":[78,91,107],"19.2":[79],"years,":[80],"history":[83],"infection":[86],"lasting":[87],"13.4":[88],"9.7":[92],"years.":[93],"All":[94],"subjects":[95,246],"were":[96,194,279,329,341,364,387],"months":[102],"(mean":[103],"17.2":[104],"10.3":[108],"months).":[109],"vast":[112],"majority":[113],"cases":[115],"(93":[116],"109:":[118],"85.3%),":[119],"multiple":[120,356],"(3-16)":[121],"prior":[122],"changes":[124],"prompted":[125],"raltegravir":[126,206,261,396,401,441],"introduction":[127],"advanced-salvage":[129],"lines:":[130],"72":[131],"(66.1%)":[134],"had":[136],"even":[137],"developed":[138],"concurrent":[140,373],"triple-class":[141],"resistance":[142],"anti-HIV":[144],"compounds.":[145],"most":[147,164],"frequent":[148],"companion":[149],"agents":[151],"were:":[152,168],"darunavir/ritonavir":[153],"(75":[154],"cases),":[155,175,181],"maraviroc":[156],"(47":[157],"subjects),":[158],"etravirine":[160],"(38":[161],"cases).":[162,187],"common":[165],"underlying":[166],"conditions":[167,269],"AIDS":[169],"(46":[170],"patients),":[171],"liver":[172,295,361],"cirrhosis":[173,296],"(31":[174],"AIDS-related":[176],"other":[178,422],"malignancies":[179,328],"(23":[180],"major":[183],"cardio-cerebro-vascular":[184],"events":[185,251],"(18":[186],"A":[188,424],"chronic":[189,288,318],"HCV":[190],"HBV":[192],"hepatitis":[193,289],"concern":[196],"48":[198,316],"23":[200],"patients,":[201],"respectively.":[202],"adjunct":[204],"favourably":[207],"affected":[208],"markers":[211],"disease":[214],"progression,":[215],"those":[217],"broad":[220],"spectrum":[221],"comorbidities,":[223],"except":[224],"two":[226],"who":[228],"failed":[229],"due":[233,354],"insufficient":[235],"adherence.":[236],"Despite":[237],"already":[239],"compromised":[240],"clinical":[241],"situation,":[242],"minority":[244],"experienced":[247],"mild-transient":[248,332],"untoward":[250],"possibly":[252],"attributable":[253],"such":[256],"that":[257],"no":[258,418],"discontinued":[260],"during":[262,272],"observation":[264],"period.":[265],"Only":[266,331],"three":[267],"AIDS-defining":[268],"became":[270,310],"apparent":[271],"raltegravir-based":[273],"cART;":[274],"chemotherapy":[275],"and/or":[276,297,381],"radiotherapy":[277],"cycles":[278],"performed":[280],"scheduled":[282],"suffering":[285,371],"from":[286,372],"cancer;":[287],"B":[290],"C":[292],"progressed":[293],"hepatocarcinoma":[298],"only":[300],"2":[301],"6":[303],"patients.":[304],"Otherwise,":[305],"treatment":[306],"pegylated":[308],"interferon-ribavirin":[309],"feasible":[311],"25":[313],"HCV.":[319],"During":[320],"cART,":[322],"neither":[323],"autoimmune":[324],"disorders":[325],"nor":[326],"novel":[327,412],"diagnosed.":[330],"gastrointestinal":[333],"disorders,":[334],"fatigue,":[335],"dizziness,":[336],"insomnia":[337],"cutaneous":[339],"rash":[340],"reported,":[342],"although":[343],"their":[344],"relationship":[345],"study":[348],"drug":[349],"was":[350],"difficult":[351],"assess":[353],"comorbidities":[357],"polypharmacy.":[359],"Abnormal":[360],"function":[362],"testings":[363],"observed":[365],"57":[367],"(52.3%),":[369],"hepato-biliary":[374],"disorders.":[375],"Significant":[376],"increases":[377],"serum":[379,390],"lipids":[380],"lipase":[382],"levels":[383,392],"versus":[384],"baseline":[385],"values":[386],"never":[388],"registered:":[389],"lipid":[391],"significantly":[393],"improved":[394],"after":[395],"introduction.":[397],"Our":[398],"experience":[399],"underlines":[402],"its":[403],"excellent":[404],"efficacy":[405],"profile,":[408],"which":[409],"exploits":[410],"mechanism":[413],"action,":[415],"displays":[417],"cross-resistance":[419],"any":[421],"antiretroviral.":[423],"progressively":[425],"extended":[426],"prescription":[427],"naive":[429],"early":[432],"lines":[434],"will":[435],"allow":[436],"therapeutic":[438],"potential":[439],"be":[443],"exploited.":[444]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}